Saturday 9 November 2024

The Pharmaletter

One To Watch

wockhardt

Wockhardt

Want to Update your Company's Profile?


Latest Wockhardt News

Wockhardt’s antibiotic Miqnaf recommended by CDSCO
14 October 2024
US Court orders Wockhardt unit to stop making adulterated drugs
22 August 2022
M&A deals jump in India, lifted by pharma and APIs
15 February 2022
Dr Reddy's to acquire select business divisions of Wockhardt in India
12 February 2020
More Wockhardt news >


Today's issue

US FDA to consider Dizal’s first-in-class lung cancer drug
Pharmaceutical
US FDA to consider Dizal’s first-in-class lung cancer drug
8 November 2024
Pharmaceutical
Viracta Thera pins hopes on lead lymphoma program
8 November 2024
Pharmaceutical
Pfizer unveils new China strategy with $1 billion investment
8 November 2024
Biotechnology
AlloVir announces merger with Kalaris Therapeutics
8 November 2024
Biotechnology
Health Canada approval for Moderna’s RSV vaccine
8 November 2024
Biotechnology
J&J files with EMA and FDA for Darzalex in high-risk smouldering MM
8 November 2024
Pharmaceutical
UK health data challenges and opportunities laid bare
8 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze